Los Angeles Biotechnology Network
  • Home
  • About
  • News
    • All LABN News
    • Trending LABN News
  • Jobs
    • All LABN Jobs
    • Post A Job
  • Subscribe
  • Contact
News Ticker
  • [ October 2, 2022 ] Biomechanics consultant – Semper Scientific – Mission Viejo, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Product Quality Lead – CAPRICOR THERAPEUTICS, INC – Los Angeles, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Sr. Biomanufacturing Manager, Upstream & Downstream (Cell & Gene Therapy) – Avid Bioservices – Tustin, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] Scientist, Analytical Development – Atara Biotherapeutics, Inc. – Thousand Oaks, CA Los Angeles Biotech Jobs
  • [ October 1, 2022 ] GMP Project Engineer/Sr. Engineer, Capital Projects – Avid Bioservices – Tustin, CA Los Angeles Biotech Jobs
HomeLos Angeles Biotech NewsBalt Receives IDE Approval From the FDA to Begin the STEM Trial

Balt Receives IDE Approval From the FDA to Begin the STEM Trial

May 15, 2020 Los Angeles Biotechnology Network News Los Angeles Biotech News Comments Off on Balt Receives IDE Approval From the FDA to Begin the STEM Trial
IRVINE, Calif.--(BUSINESS WIRE)--Balt receives IDE approval from the FDA to begin the STEM Trial for the treatment of chronic Sub-Dural Hematoma (cSDH).

Click to view original post

Previous

FATHOMWERX Officially Announced as Tech Bridge for NavalX

Next

Cherry Thomas joins Caribou as SVP of clinical development; Artax locks in Joseph Lobacki as CEO

Follow/Subscribe

POST A JOB
Tweets by LABioNetwork

Copyright © 2021 Biotech Networks, LLC

Want to Save Time?

Get Trending News & Jobs Delivered